Serum NT-proBNP for predicting left ventricular systolic dysfunction in hospitalized patients in Sri Lanka
| dc.contributor.author | Rathnayake,B.M.C. | |
| dc.contributor.author | Illeperuma,R.P. | |
| dc.contributor.author | Jayasinghe,S. | |
| dc.contributor.author | Fawcett,T.N. | |
| dc.contributor.author | Maduwage,K. | |
| dc.contributor.author | Jayalath,W.A.T.A. | |
| dc.contributor.author | Ralapanawa,U. | |
| dc.date.accessioned | 2025-11-17T05:33:31Z | |
| dc.date.available | 2025-11-17T05:33:31Z | |
| dc.date.issued | 2023-09-20 | |
| dc.description.abstract | Limited research has delved into the significance of N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) in the detection of Left Ventricular Systolic Dysfunction (LVSD) in South Asian populations. Therefore, current observational study was aimed at assessing the use of serum NT-proBNP levels in predicting LVSD in a hospitalised population in Sri Lanka. A random sample of 278 prospective patients referred for echocardiography at Teaching Hospital, Peradeniya provided the consent and venous blood samples were collected for serum NT-proBNP assay by sandwich ELISA method. Then, based on the ejection fraction (LVEF) and fractional shortening (FS), participants were differentiated as LVSD patients (LVEF<50%, FS≤ 29%) and non-LVSD individuals (LVEF>60%). SPSS version 26 was used for results analysis in terms of non-parametric statistical tests. A total of 173 were finally eligible for the analysis, in which 100 were LVSD patients and 73 were non-LVSD individuals. The mean ages of the LVSD and non-LVSD groups were 69.1 (±6.2 years) and 70.8 (±3.8 years) (p=0.718) respectively, suggesting that LVSD is mostly a disease of elderly. The median NT-proBNP value (with IQR) among LVSD patients (528.2 pg/mL,355.2–924.2) was comparatively higher than that of non-LVSD individuals (204 pg/mL,175.5–306.8). NT-proBNP levels gradually increase through non-LVSD, mild, moderate and severe LVSD groups (Kruskal-Wallis H(3)=122.6, p<0.001). Strong correlations of log NT-proBNP level with LVEF (Spearman rho = - 0.859, p<0.001), FS (rho= -0.812, p <0.001) and LV mass (rho= 0.727, p<0.001) suggested that NT-proBNP concentration in serum increases in parallel to deteriorating left ventricular functions. The area under receiver operating curve of serum NT-proBNP for differentiating LVSD was 0.866 (95% CI:0.801 – 0.931) and the optimal cut-off level of NT-proBNP for predicting LVSD was 265pg/mL with 90% sensitivity and 70% specificity. Therefore, the current Sri Lankan study revealed a considerable correlation of serum NT-proBNP level with the severity of LVSD, and the proposed cut-off level can be an optimal reference point to predict LVSD in high- risk local individuals. | |
| dc.description.sponsorship | This study was financially (partially) supported by the Peradeniya University Research Grant under the project number (URG/2021/04/AHS). | |
| dc.identifier.citation | Proceedings of the Peradeniya University International Research Sessions (iPURSE) – 2023, University of Peradeniya, P 58-59 | |
| dc.identifier.uri | https://ir.lib.pdn.ac.lk/handle/20.500.14444/6701 | |
| dc.language.iso | en_US | |
| dc.publisher | University of Peradeniya, Sri Lanka | |
| dc.subject | Serum | |
| dc.subject | NT-proBNP | |
| dc.subject | Left Ventricular Systolic Dysfunction | |
| dc.subject | Natriuretic peptides | |
| dc.subject | Left Ventricular Ejection Fraction | |
| dc.title | Serum NT-proBNP for predicting left ventricular systolic dysfunction in hospitalized patients in Sri Lanka | |
| dc.type | Article |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: